Trade Gilead ^GILD

KBC Group NV Has $373.46 Million Stock Position in Gilead Sciences, Inc. $GILD - Zolmax

Pharmaceutical Stocks To Research - July 20th - Daily Political

KBC Group NV Has $373.46 Million Stake in Gilead Sciences, Inc. $GILD

Dimensional Fund Advisors LP Lowers Stock Holdings in Gilead Sciences, Inc. $GILD

FY2026 EPS Forecast for Gilead Sciences Boosted by Analyst

Swiss National Bank Buys 240,800 Shares of Gilead Sciences, Inc. $GILD

SEB Asset Management AB Invests $171.84 Million in Gilead Sciences, Inc. $GILD

Gilead Sciences, Inc. $GILD Shares Sold by Financiere des Professionnels Fonds d investissement inc. - Markets Daily

Dorsey Wright & Associates Acquires New Stake in Gilead Sciences, Inc. $GILD - Markets Daily

Swiss National Bank Has $507.45 Million Holdings in Gilead Sciences, Inc. $GILD - Stock Observer

Assetmark Inc. Cuts Stock Position in Gilead Sciences, Inc. $GILD

Jennison Associates LLC Has $176.24 Million Stake in Gilead Sciences, Inc. $GILD - Stock Observer

Gilead Stock Tops 3 GARP Picks Trading On More Measured Valuations

Gilead Sciences synthesizes new KRAS mutant inhibitors

Jag Capital Management LLC Increases Stake in Gilead Sciences, Inc. $GILD

Sigma Planning Corp Sells 7,783 Shares of Gilead Sciences, Inc. $GILD

Gilead Sciences, Inc. $GILD Shares Bought by D.A. Davidson & CO.

Comparison of obecabtagene autoleucel versus an external control arm in adult patients with relapsed/refractory B-cell acute lymphoblastic leukemia

Is Gilead Sciences (GILD) Fully Valued Following Mixed Earnings And A Full Year EPS Miss?

Sanctuary Advisors LLC Cuts Stock Holdings in Gilead Sciences, Inc. $GILD

Englumafusp alfa plus glofitamab in B cell non-Hodgkin lymphoma: a phase 1 trial

Is the Bearishness Around Pfizer and Gilead Sciences a Contrarian Opportunity?

Should Gilead's Revenue Beat but Softer EPS Outlook Require Action From Gilead Sciences (GILD) Investors?

Diversify Wealth Management LLC Acquires 5,072 Shares of Gilead Sciences, Inc. $GILD - Daily Political

Bleakley Financial Group LLC Acquires 24,649 Shares of Gilead Sciences, Inc. $GILD - Daily Political

Calamos Advisors LLC Raises Stock Holdings in Gilead Sciences, Inc. $GILD

J. Safra Sarasin Holding AG Lowers Stock Position in Gilead Sciences, Inc. $GILD

Gilead Sciences, Inc. (NASDAQ:GILD) Given Average Rating of "Moderate Buy" by Analysts - Zolmax

Gilead Sciences, Inc. (NASDAQ:GILD) Receives Consensus Rating of "Moderate Buy" from Brokerages

AMF Tjanstepension AB Buys 17,302 Shares of Gilead Sciences, Inc. $GILD

Procyon Advisors LLC Increases Stock Position in Gilead Sciences, Inc. $GILD - Stock Observer

Teachers Retirement System of The State of Kentucky Has $85.62 Million Holdings in Gilead Sciences, Inc. $GILD - Daily Political

Gilead Sciences (NASDAQ:GILD) Raised to Buy at Wall Street Zen

Gilead Sciences (NASDAQ:GILD) Rating Increased to Buy at Wall Street Zen

Fifth Third Bancorp Purchases 226,510 Shares of Gilead Sciences, Inc. $GILD

Wells Fargo Reaffirms Their Buy Rating on Eli Lilly & Co (LLY)

Candriam S.C.A. Has $232.79 Million Holdings in Gilead Sciences, Inc. $GILD

Conning Inc. Decreases Position in Gilead Sciences, Inc. $GILD

Gilead Sciences Down Over 4%, on Pace for Largest Percent Decrease Since July 2025 - Data Talk | Morningstar

Ibex Wealth Advisors Has $2.14 Million Holdings in Gilead Sciences, Inc. $GILD

Gilead (GILD) Stock Looks Below Fair Value But Earnings Already Look Priced In

Sumitomo Mitsui Trust Group Inc. Trims Stock Position in Gilead Sciences, Inc. $GILD - Zolmax

Sumitomo Mitsui Trust Group Inc. Decreases Position in Gilead Sciences, Inc. $GILD - Markets Daily

Resona Asset Management Co. Ltd. Has $58.67 Million Stake in Gilead Sciences, Inc. $GILD - Stock Observer

Morgan Stanley Keeps Buy Rating on Gilead (GILD)

Pharmaceutical Stocks To Watch Now - July 8th - Markets Daily

Gilead Sciences (NASDAQ:GILD) Price Target Cut to $166.00 by Analysts at Morgan Stanley

Gilead Sciences (GILD) Could Be 53% Below Fair Value After Trodelvy Approval

O Domhnaill Enterprises Inc. Makes New Investment in Gilead Sciences, Inc. $GILD - Zolmax

15,198 Shares in Gilead Sciences, Inc. $GILD Acquired by O Domhnaill Enterprises Inc.

Gilead Sciences (NASDAQ:GILD) Given New $156.00 Price Target at Truist Financial

Swedbank AB Has $334.21 Million Stock Holdings in Gilead Sciences, Inc. $GILD - Daily Political

Bispecific 10E8.4/iMab broadly neutralizing antibody in people with or without HIV-1: a partially randomized phase 1 trial

Gilead Sciences' (GILD) Overweight Rating Reaffirmed at Cantor Fitzgerald

Here Are Monday's Best Wall Street Analyst Research Calls: Agnico Eagle Mines, Datadog, Delta Air Lines, Gilead Sciences, Okta, Pfizer, Regions Financial, T-Mobile, and More

Raleigh Capital Management Inc. Sells 6,614 Shares of Gilead Sciences, Inc. $GILD

Experimental Ebola trial begins in Congo as death toll tops 500

Should First-Line Trodelvy Breast Cancer Approvals Reshape the Gilead Sciences (GILD) Investment Narrative?

Is Gilead (GILD) One of the Most Undervalued NASDAQ Stocks to Buy Right Now?

Gilead Sciences, Inc. $GILD Shares Bought by Kepler Cheuvreux Suisse SA

Berger Financial Group Inc Trims Stock Position in Gilead Sciences, Inc. $GILD

HB Wealth Management LLC Acquires 5,516 Shares of Gilead Sciences, Inc. $GILD - Daily Political

Rep. Jared Moskowitz Purchases Gilead Sciences, Inc. (NASDAQ:GILD) Stock - Daily Political

Top Pharmaceutical Stocks To Follow Today - July 4th

QRG Capital Management Inc. Sells 15,139 Shares of Gilead Sciences, Inc. $GILD - Markets Daily

QRG Capital Management Inc. Trims Stake in Gilead Sciences, Inc. $GILD - Zolmax

Rep. Jared Moskowitz Buys Shares of Gilead Sciences, Inc. (NASDAQ:GILD) - Stock Observer

Strs Ohio Sells 30,448 Shares of Gilead Sciences, Inc. $GILD - Zolmax

Healthcare Stocks Investors Are Turning To After The Weak US Jobs Report

Y Intercept Hong Kong Ltd Buys Shares of 104,293 Gilead Sciences, Inc. $GILD

Global TROP-2 Targeted Therapy Market Set to Reach USD 3.29 Billion by 2031 with an 8.6% CAGR

Fulton Bank N.A. Sells 9,171 Shares of Gilead Sciences, Inc. $GILD

Gilead Sciences, Inc. $GILD Shares Purchased by Turtle Creek Wealth Advisors LLC - Daily Political

Gilead Sciences (NASDAQ:GILD) CEO Sells 15,000 Shares of Stock

Casdatifan 在肾癌中表现出与 HIF-2α 生物学相关的持久疗效

iA Global Asset Management Inc. Trims Stake in Gilead Sciences, Inc. $GILD

Gilead Sciences, Inc. $GILD Shares Purchased by USS Investment Management Ltd - Stock Observer

iA Global Asset Management Inc. Reduces Position in Gilead Sciences, Inc. $GILD - Stock Observer

Therapeutics Stocks Q1 Recap: Benchmarking Vertex Pharmaceuticals (NASDAQ:VRTX)

Forum Financial Management LP Sells 9,759 Shares of Gilead Sciences, Inc. $GILD - Zolmax

Forum Financial Management LP Decreases Stock Holdings in Gilead Sciences, Inc. $GILD - Markets Daily

Janney Montgomery Scott LLC Sells 11,021 Shares of Gilead Sciences, Inc. $GILD

Patton Fund Management Inc. Has $3.01 Million Stock Holdings in Gilead Sciences, Inc. $GILD - Markets Daily

Patton Fund Management Inc. Sells 38,011 Shares of Gilead Sciences, Inc. $GILD

MFA Wealth Services Purchases Shares of 7,677 Gilead Sciences, Inc. $GILD - Markets Daily

Pictet Asset Management Holding SA Buys 218,308 Shares of Gilead Sciences, Inc. $GILD - Stock Observer

How Trodelvy's New First-Line Breast Cancer Role Could Reframe Gilead Sciences' (GILD) Investment Narrative

Medical Stocks To Follow Now - June 27th - Zolmax

Pharmaceutical Stocks To Research - June 27th - Daily Political

US Economy on Stagflation Watch: Apollo Global Management's Outlook

AI Podcast: Fresh Insights on Fed Rate Cut Timing - News in a New Way

The Week Ahead: ISM services, SMCI

Week ahead: Wall Street’s Magnificent Seven earnings are up

Week ahead: Earnings season climax

Week ahead: RBA poised to hike?

Week ahead: Megacap tech and 1-in-3 Dow components set to report

Trump's Sudden Russia Policy Shift: Rubio's Influence and Implications

Global Market Review: Gold Volatility and Tech Stock Surge Amidst Economic Uncertainty

September CPI Data: Inflation Hurdles, Tariff Impacts, and Fed Rate Cut Expectations

Navigating the AI Boom: Strategies for Investors Amid Nvidia's Valuation Surge

Fund Managers Cautious in Q4: AI, Inflation, and Monetary Policy in Focus

US Government Shutdown Threatens October Inflation Data Release

US-EU Relations: Russia Sanctions Unite Despite Trade Tensions

BOJ Warns of Japan Stock Market Overheating, U.S. Trade Policy Risk